Gilead Sciences Inc will invest $5.1 billion to raise its stake in Galapagos NV ...
) and partner with the Belgian-Dutch biotech firm to develop and commercialize its treatments for a ten-year period, the companies said on Sunday.
“Gilead gains exclusive access to all current and future compounds in Galapagos’ rich pipeline while Galapagos is able to expand its research activities and build commercial infrastructure,” Gilead Chief Executive Officer Daniel O’Day said in a statement. In 2015, Gilead signed a deal worth more than $2 billion with Galapagos, which included a $725 million upfront payment for the development of filgotinib, as well as an equity stake in the European firm.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Gilead to Boost Stake in Belgian Biotech Galapagos as Part of $5.1 Billion DealGilead Sciences will pay $5.1 billion to lift its stake in Galapagos NV and gain rights outside Europe to the Belgian biotechnology company’s treatments in development.
Consulte Mais informação »
All The Makeup Details You're Overlooking In 'The Handmaid's Tale'There's more to the makeup looks of Gilead than meets the eye.
Consulte Mais informação »
Gilead to Boost Stake in Belgian Biotech Galapagos as Part of $5.1 Billion DealGilead Sciences will pay $5.1 billion to lift its stake in Galapagos NV and gain rights outside Europe to the Belgian biotechnology company’s treatments in development.
Consulte Mais informação »
IMF to ship $5.4 billion to Argentina under standby loan dealThe International Monetary Fund board said on Friday it would ship $5.4 billion ...
Consulte Mais informação »